Biosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and Haematology

NCT02158169 · clinicaltrials.gov ↗

COMPLETED

Status

2167

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Anemia

Sponsor

Hospira, now a wholly owned subsidiary of Pfizer